Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026)
Bionano Genomics (BNGO) posted Amortizatization of Intangibles of $194000.0 for Q1 2026, up 137.09% sequentially from -$523000.0 in Q4 2025, and down 19.83% YoY from $242000.0 in Q1 2025.
Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Bionano Genomics has reported Amortizatization of Intangibles for 6 years, with the latest figure at $194000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 19.83% year-over-year to $194000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156000.0 (down 81.94% YoY) and the FY2025 annual result came in at $204000.0, down 84.5% from the prior year.
- Amortizatization of Intangibles climbed to $194000.0 in Q1 2026 per BNGO's latest filing, from -$523000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.2 million in Q4 2024 and troughed at -$759000.0 in Q3 2024.
- A 5-year average of $95000.0 and a median of $57000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 1260.78% in 2024, down 1588.24% in 2024.
- Over 5 years, Amortizatization of Intangibles stood at $57000.0 in 2022, then surged by 577.19% to $386000.0 in 2023, then soared by 201.3% to $1.2 million in 2024, then slumped by 144.97% to -$523000.0 in 2025, then soared by 137.09% to $194000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $194000.0, -$523000.0, and $236000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 38.80 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 10.34 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 500,000.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | 109,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109,000.00 |
| Jun 30, 2026 | 109,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | -523,000.00 |
| Dec 31, 2025 | -523,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | -759,000.00 |
| Sep 30, 2024 | -759,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 694,000.00 |
| Mar 31, 2024 | 694,000.00 |